Acurx Pharmaceuticals Ownership | Who Owns Acurx Pharmaceuticals?


OverviewFinancialsChartTranscripts

Acurx Pharmaceuticals Ownership Summary


Acurx Pharmaceuticals is owned by 7.63% institutional investors, 14.80% insiders, and 77.57% retail investors. Vanguard group is the largest institutional shareholder, holding 3.18% of ACXP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.27% of its assets in Acurx Pharmaceuticals shares.

ACXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAcurx Pharmaceuticals7.63%14.80%77.57%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group491.69K3.18%$1.11M
Prospect financial services329.08K2.01%$267.87K
Geode capital management130.01K0.84%$292.57K
Lpl financial53.73K0.35%$120.90K
Morgan stanley46.40K0.30%$104.40K
State street43.47K0.28%$97.80K
Blackrock27.50K0.18%$61.88K
Northern trust27.29K0.18%$61.39K
Act advisors, llc.21.28K0.13%$17.32K
Td waterhouse canada18.66K0.12%$39.92K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prospect financial services329.08K0.15%$267.87K
Act advisors, llc.21.28K0.01%$17.32K
Semmax financial advisors5.88K0.00%$11.17K
Nbc securities19.000.00%$15.00
Patriot financial group insurance agency10.38K0.00%$8.45K
Cornerstone planning group3.34K0.00%$2.81K
Td waterhouse canada18.66K0.00%$39.92K
Tocqueville asset management10.00K0.00%$22.50K
Tower research capital llc (trc)4.14K0.00%$9.31K
Advisor group15.21K0.00%$34.22K

Top Buyers

HolderShares% AssetsChange
Prospect financial services329.08K0.15%34.00K
Act advisors, llc.21.28K0.01%21.28K
Morgan stanley46.40K-20.00K
Geode capital management130.01K-13.66K
Lpl financial53.73K0.00%13.50K

Top Sellers

HolderShares% AssetsChange
Advisor group15.21K0.00%-42.04K
Susquehanna group, llp---37.44K
Nbc securities19.000.00%-18.98K
Xtx topco---13.04K
Two sigma investments, lp---12.99K

New Positions

HolderShares% AssetsChangeValue
Act advisors, llc.21.28K0.01%21.28K$17.32K
Northwestern mutual wealth management1.64K-1.64K$3.68K
Ubs group881.00-881.00$1.98K

Sold Out

HolderChange
Wells fargo & company/mn-87.00
Cambridge investment research advisors-10.00K
Two sigma investments, lp-12.99K
Xtx topco-13.04K
Susquehanna group, llp-37.44K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202423-11.54%1,248,3143.50%712.55%6-45.45%650.00%
Jun 30, 202426-3.70%1,206,131-3.41%78.03%11-35.29%433.33%
Mar 31, 2024278.00%1,248,67614.30%913.97%17-10.53%3200.00%
Dec 31, 20232547.06%1,092,46224.40%816.18%1958.33%1-66.67%
Sep 30, 20231741.67%878,194-40.86%74.43%1250.00%3200.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv383.81K2.27%-
Vanguard Institutional Extnd Mkt Idx Tr145.54K0.86%-
Fidelity Extended Market Index76.81K0.45%-506.00
iShares Micro-Cap ETF22.42K0.13%-
Fidelity Total Market Index20.03K0.12%-
Northern Trust Extended Eq Market Idx18.93K0.12%-
NT Ext Equity Mkt Idx Fd - L18.93K0.11%-
Fidelity Series Total Market Index18.30K0.11%-
Spartan Extended Market Index Pool E12.88K0.08%506.00
Fidelity Nasdaq Composite Index11.33K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2025Scodari Joseph C-Buy$25.00K
Jan 06, 2025Scodari Joseph C-Buy$22.17K
Jan 06, 2025Sailer Carl-Buy$25.00K
Jan 06, 2025Sailer Carl-Buy$22.17K
Jan 06, 2025LUCI DAVID P President and CEOBuy$50.00K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q2--
2023 Q1--

ACXP Ownership FAQ


Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals shareholders are primarily institutional investors at 7.63%, followed by 14.80% insiders and 77.57% retail investors. The average institutional ownership in Acurx Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Acurx Pharmaceuticals falls below.

Who owns the most shares of Acurx Pharmaceuticals?

Acurx Pharmaceuticals’s largest shareholders are Vanguard group (491.69K shares, 3.18%), Prospect financial services (329.08K shares, 2.01%), and Geode capital management (130.02K shares, 0.84%). Together, they hold 6.03% of Acurx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acurx Pharmaceuticals?

Yes, BlackRock owns 0.18% of Acurx Pharmaceuticals, totaling 27.5K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 61.88K$. In the last quarter, BlackRock increased its holdings by 8.82K shares, a 47.17% change.

Who is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Prospect financial services is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 329.08K Acurx Pharmaceuticals shares, valued at 267.87K$.

Who is the top mutual fund holder of Acurx Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Acurx Pharmaceuticals shares, with 2.27% of its total shares outstanding invested in 383.81K Acurx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools